Effect of Hyperthermia at 40.5° C and Cytostatic Drugs on Human Bone Marrow Progenitor Cells

  • H. A. Neumann
  • R. Engelhardt
Conference paper
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 109)


Hyperthermia in clinical treatment is mostly used locally, either alone or in combination with radio- or chemotherapy. In the treatment of local tumors, this modality is of proven therapeutic benefit (Cavaliere et al. 1982; Dewhirst et al. 1983). A small group of clinicians, however, have tried to apply whole body hyperthermia. Their therapeutic aim is the thermal enhancement of cytostatic drug effects in the treatment of disseminated malignancies (Pettigrew et al. 1974; Barlogie et al. 1979; Bull et al. 1979; Parks et al. 1979; Neumann et al. 1982). In using this modality, it is of critical importance to know whether hyperthermia can damage normal bone marrow and, if enhancement of cytostatic drug effects is indeed achieved, whether the action might be not only on the tumor cells but also on the bone marrow cells. It was therefore the aim of our study to establish whether hyperthermia can enhance the cytotoxicity of several cytostatic drugs on normal human bone marrow cells. For the clinical application of whole body hyperthermia the temperatures and the treatment times must be restricted to a tolerable level. We therefore used a temperature of 40.5° C for 2 h.


Bone Marrow Cell Colony Formation Mouse Bone Marrow Normal Bone Marrow Cytostatic Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aye MT, Niho Y, Till JE, McCulloch EA (1977) Studies of leukemic cell populations in culture. Blood 44: 205–214Google Scholar
  2. Balogie B, Corry PM, Yip E, Lippmann I, Johnston DA, Khalil K, Tenczynski TF, Reilly E, Lawson R, Dosik G, Rigor B, Hankenson R, Freireich EJ (1979) Total-body hyperthermia with and without chemotherapy for advanced neoplasms. Cancer Res 39: 1481–1489Google Scholar
  3. Bromer RH, Mitchell JB, Soares N (1982) Response of human hematopoietic precursor cells (CFU-C) to hyperthermia and radiation. Cancer Res 42: 1261–1265PubMedGoogle Scholar
  4. Bull JM, Lees DE, Schutte WH, Wang Pang J, Smith R, Bynum G, Atkinson ER, Gottdiener JS, Gralnik HR, Shawker TH, de Vita VT (1979) Whole body hyperthermia: a phase I trial of a potential adjuvant to chemotherapy. Ann Intern Med 90: 317–323PubMedGoogle Scholar
  5. Cavaliere R, Di Filippo F, Moricca G, Santori F, Varahese A, Pantano FP, Cassanelli A, Aloe L, Monticelli G (1982) Hyperthermic perfusion for treatment of tumors of the extremities. Chemotherapy 1: 278–287Google Scholar
  6. Dewhirst MW, Sim DA, Wilson S, de Young D, Parsells JL (1983) Correlation between initial and long term responses of spontaneous pet animal tumors to heat and radiation or radiation alone. Cancer Res 43: 5735–5741PubMedGoogle Scholar
  7. Elkon D, Dabio H, McGrath HE, Baker DG (1981) Temperature-dependent inhibition of murine granulocyte-monocyte precursors. Cancer Res 41: 1812–1816PubMedGoogle Scholar
  8. Fauser AA, Messner HA (1978) Granuloerythropoietic colonies in human bone marrow, peripheral blood and cord blood. Blood 52: 1243–1248PubMedGoogle Scholar
  9. Hahn GM (1983) Hyperthermia to enhance drug delivery. In: Chabner BA (ed) Rational basis for chemotherapy, UCLA symp on molecular and cellular biology-new series, vol.4. UCLA symposium on the rational basis for chemotherapy, Keystone, CO 1982. Liss, New York, pp 427–436Google Scholar
  10. Neumann HA, Fabricius HA, Engelhardt R (1982) Moderate whole-body hyperthermia in combination with chemotherapy in the treatment of small cell carcinoma of the lung: a pilot study. Natl Cancer Inst Monogr 61: 427–429Google Scholar
  11. O’Donnel JF, McKoy WS, Makuch RW, Bull JM (1979) Increased in vitro toxicity to mouse bone marrow with 1,3-bis (2-chloroethyl) 1-nitrosourea and hyperthermia. Cancer Res 39: 1547–2549Google Scholar
  12. Parks LC, Ninaberry D, Smith DP, Neely WA (1979) Treatment of far advanced bronchogenic carcinoma by extracorporally induced systemic hyperthermia. J Thorac Cardiovasc Surg 78: 883–892PubMedGoogle Scholar
  13. Pettigrew RT, Galt JM, Ludgate CM, Smith AN (1974) Clinical effects of whole-body hyperthermia in advanced malignancy. Br Med J 21: 679–682CrossRefGoogle Scholar
  14. Till JE, McCulloch EA (1961) Direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14: 213–222PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • H. A. Neumann
    • 1
  • R. Engelhardt
    • 1
  1. 1.St. Josef Hospital, Medizinische KlinikRuhr-UniversitätBochumGermany

Personalised recommendations